Liquidity	9 Months Ended
Liquidity	Oct. 31, 2025
Liquidity [Abstract]
Liquidity	Liquidity The Company has experienced year-over-year revenue growth during the three and nine months ended October 31, 2025. The Company recognized net income from operations of $76.5 million and $24.0 million for the three and nine months ended October 31, 2025, respectively, due to the recognition of a Gain on Debt Restructuring of $96.3 million during the three months ended October 31, 2025. Prior to the third quarter of fiscal year 2025, the Company incurred significant recurring net losses since inception and has an accumulated deficit of $(1,099.0) million as of October 31, 2025. The Company has historically relied on debt and equity financing to fund its operations. The Company’s cash flows (used in) from operations for the nine months ended October 31, 2025 were $(3.6) million compared to $11.5 million for the nine months ended October 31, 2024. Cash out flows from investing activities for the nine months ended October 31, 2025 were $(42.9) million compared to $(20.8) million for the nine months ended October 31, 2024. As of October 31, 2025, the Company held cash and cash equivalents of $50.7 million and long-term debt of $159.1 million with a maturity date in October 2029. The Company experienced year-over-year revenue growth and a reduction in net losses in fiscal years 2024 and 2023 and significantly reduced its cash outflows from operations plus cash outflows generated (used) in investing during the year ended January 31, 2025. Excluding the Gain on Debt Restructuring discussed above, the Company experienced an increase in net loss during the three and nine months ended October 31, 2025 as compared to the three and nine months ended October 31, 2024. The Company also experienced an increase in cash outflows as measured by cash flows from operations plus cash flows generated (used) in investing during the nine months ended October 31, 2025 as compared to the nine months ended October 31, 2024 due to a strategic, intentional increase in its investment in rental product and unit purchases for fiscal year 2025. To the extent the Company is impacted by macroeconomic trends, or other factors, including, but not limited to, lower demand for our business, increased rental product spend, or tariffs, the Company plans to preserve liquidity by reducing fixed and variable costs, which may include additional reductions to labor, operating expenses, and/or capital expenditures. However, these actions may not provide sufficient incremental liquidity to fund the Company’s long-term obligations. On August 20, 2025, concurrent with the Company’s entry into the Exchange Agreement (as defined below), the Company entered into a Fourteenth Amendment to the Credit Agreement with CHS (US) Management LLC, as administrative agent, and CHS US Investments LLC, as lender (the “Fourteenth Amendment”) (the 2023 Amended Temasek Facility, as amended by the Eleventh Amendment, Twelfth Amendment, Thirteenth Amendment and Fourteenth Amendment, the “2025 Amended Facility”). The Fourteenth Amendment provided that, among other things, (i) interest that would otherwise be payable in cash will be capitalized, (ii) the liquidity financial covenant level will temporarily be reduced from $30 million to $15 million until the closing of the transactions contemplated by the Recapitalization Transactions (as defined below), and (iii) the spend levels for fiscal year 2025 are eliminated. On October 28, 2025, the Company completed the previously announced Recapitalization Transactions to enhance the Company’s financial position and flexibility by significantly reducing its existing indebtedness, improving its borrowing rate and extending the maturity of its remaining indebtedness. Under the terms of the Recapitalization Transactions, the Company entered into the New Credit Agreement (as defined below). The Company’s lender exchanged $100 million of existing outstanding indebtedness on a dollar-for-dollar cashless basis for new term loans and exchanged the remaining indebtedness for 26,175,193 newly issued shares of the Company’s Class A Common Stock. The Company also received an additional $20 million of new term loans excluding direct costs related to the transactions, resulting in an aggregate principal amount of $120 million. The Company also received $12.5 million in proceeds from a concurrent Rights Offering (as defined below). Additionally, the Company’s minimum liquidity maintenance covenant was also reduced from $30 million to $15 million until February 20, 2027. See “Note 4 - Recapitalization Transactions” for additional information. The Company believes that it will have sufficient liquidity from cash on-hand and future operations to sustain its business operations, to satisfy its debt service obligations, and to comply with its debt covenants for at least the next twelve months from the date these financial statements are issued.